|
David E. Levy, M.D., was appointed vice president of clinical development of Neurobiological Technologies, Inc. (NTI) in August 2004. Before joining NTI, he was international project team leader at Eisai Medical Research, Inc. where he directed clinical programs for Alzheimer’s disease and acute ischemic stroke. Previously, he served as an advisor to Empire Pharmaceuticals and as senior director of medical research at DOV Pharmaceutical. From 1991 to 2001, Dr. Levy was with Knoll Pharmaceuticals last serving as, senior director of cardiovascular/internal medicine. Dr. Levy’s academic career includes 23 years at Weill-Cornell Medical College and New York Presbyterian Hospital. Levy earned his B.A. in chemistry and physics, cum laude, from Harvard College and his doctor of medicine degree from Harvard Medical School. | 